Human papillomavirus (HPV) genotyping and prognostic value of HPV E4 protein and transcription factors NANOG and SOX11 in atypical p16 patchy squamous epithelium of cervix
, , and
Jul 08, 2025
About this article
Article Category: Research Article
Published Online: Jul 08, 2025
Page range: 391 - 402
Received: Mar 16, 2025
DOI: https://doi.org/10.2478/raon-2025-0038
Keywords
© 2025 Maja Kebe Radulovic et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Figure 1.

Figure 2.

Figure 3.

Figure 4.

Biomarkers in the primary biopsy and follow-up in the groups with atypical squamous epithelium with a patchy and a null reaction to p16
Group | Case | Ki67 | E4 HPV | Nanog | HPV genotypes | Follow-up sample | Follow-up diagnosis | Time from primary biopsy to follow-up sample |
---|---|---|---|---|---|---|---|---|
1 | 1/3 | - | 1+ | 31, 52 | biopsy | CIN1 | 2 years | |
2 | 3/3 | - | - | 53 | biopsy | CIN2 | 2 years | |
3 | 1/3 | - | - | - | biopsy | CIN3 | 4 months | |
4 | 0 | - | - | 39 | cone | CIN1 | 8 months | |
5 | 1/3 | - | - | - | cone | CIN1 | 6 years | |
6 | 3/3 | - | 1+ | 53 | cone | CIN3 | 5 years | |
7 | 3/3 | - | - | 52, 53, 56, 66, 73 | Cervical amputation | CIN3 | 10 months | |
8 | 1/3 | - | - | 44 | cone | CIN3 | 10 months |
Comparison of different biological markers between groups using Spearman correlation
Groups | p16 | Ki67 | HPV E4 | Nanog | lrHPV tissue | hrHPV tissue | hrHPV: tissue+smear | lrHPV: tissue+smear |
---|---|---|---|---|---|---|---|---|
p16 null vs. p16 patchy | r |
r |
r |
r |
r |
r |
||
p16 patchy vs. condyloma | r = 0.000 | r =0.280 | r = 0.000 | r=-0.186 | ||||
p16 patchy vs. CIN1 | r = 0.161 | r = -0.039 | ||||||
p16 patchy vs. CIN2 | r = -0.193 | r = 0.176 | r = -0.089 | |||||
p16 patchy vs. CIN3 | r = 0.280 | |||||||
p16 null vs. condyloma | r = 0.369 | r = 0.066 | ||||||
p16 null vs. CIN1 | r = 0.394 | r = 0.233 | ||||||
p16 null vs. CIN2 | r = 0.000 | r = 0.204 | ||||||
p16 null vs. CIN3 | r = 0.369 | r = -0.302 | r = -0.302 | |||||
Atypia (p16 patchy and null) vs. CIN2 | r = -0.125 | r = 0.231 | r = -0.007 |
Immunohistochemical reactions to various biological markers and human papillomavirus (HPV) genotyping in tissue biopsy and previous cervical smear, where available, by study group
Group | p16 | N | Ki67 | N | E4 HPV | N | Nanog | N | HPV genotyping | N tissue | N smear |
---|---|---|---|---|---|---|---|---|---|---|---|
Null | 11 | 0 | 5 | Neg. | 11 | Neg. | 7 | Neg | 9 | 3 | |
Patchy | 0 | 1/3 | 4 | Pos. | 0 | 1 | 4 | lrHPV only | 2 | 1 | |
En Block | 0 | 2/3 | 0 | 2 | 0 | hrHPV | 0 | 3 | |||
3/3 | 2 | 3 | 0 | ||||||||
Null | 0 | 0 | 12 | Neg. | 23 | Neg. | 13 | Neg | 10 | 2 | |
Patchy | 24 | 1/3 | 5 | Pos. | 1 | 1 | 11 | lrHPV only | 6 | 2 | |
En Block | 0 | 2/3 | 3 | 2 | 0 | hrHPV | 8 | 12 | |||
3/3 | 4 | 3 | 0 | ||||||||
Null | 0 | 0 | 0 | Neg. | 7 | Neg. | 0 | Neg | 0 | 1 | |
Patchy | 9 | 1/3 | 2 | Pos. | 2 | 1 | 9 | lrHPV only | 6 | 2 | |
En Block | 0 | 2/3 | 1 | 2 | 0 | hrHPV | 3 | 1 | |||
3/3 | 6 | 3 | 0 | ||||||||
Null | 0 | 0 | 2 | Neg. | 2 | Neg. | 0 | Neg | 0 | 0 | |
Patchy | 10 | 1/3 | 2 | Pos. | 10 | 1 | 12 | lrHPV only | 6 | 1 | |
En Block | 2 | 2/3 | 4 | 2 | 0 | hrHPV | 6 | 3 | |||
3/3 | 4 | 3 | 0 | ||||||||
Null | 0 | 0 | 0 | Neg. | 3 | Neg. | 0 | Neg | 1 | 0 | |
Patchy | 0 | 1/3 | 0 | Pos. | 8 | 1 | 7 | lrHPV only | 2 | 0 | |
En Block | 11 | 2/3 | 2 | 2 | 4 | hrHPV | 8 | 3 | |||
3/3 | 9 | 3 | 0 | ||||||||
Null | 0 | 0 | 0 | Neg. | 7 | Neg. | 1 | Neg | 0 | 0 | |
Patchy | 0 | 1/3 | 0 | Pos. | 2 | 1 | 3 | lrHPV only | 0 | 0 | |
En Block | 9 | 2/3 | 0 | 2 | 3 | hrHPV | 9 | 4 | |||
3/3 | 9 | 3 | 2 |
j_raon-2025-0038_Utab_001
1 | |
0,9 | |
0,8 | |
0,7 | |
0,6 | |
0,5 | |
0,4 | |
0,3 | |
0,2 | |
0,1 | |
0 | |
-0,1 | |
-0,2 | |
-0,3 | |
-0,4 | |
-0,5 | |
-0,6 | |
-0,7 | |
-0,8 | |
-0,9 | |
-1 |
Follow-up histology, cytology, human papillomavirus (HPV) result by study groups (p16 null and p16 patchy)
Group | Follow up histo | N | Follow up cyto | N | Follow up HPV | N |
---|---|---|---|---|---|---|
Neg | 0 | Neg | 5 | Neg | 5 | |
CIN1 | 1 | ASC-US | 4 | Pos | 3 | |
CIN2 | 1 | LSIL | 0 | |||
CIN3 | 1 | HSIL | 0 | |||
Neg | 0 | Neg | 5 | Neg | 4 | |
CIN1 | 2 | ASC-US | 6 | Pos | 5 | |
CIN2 | 0 | LSIL | 4 | |||
CIN3 | 3 | HSIL | 2 |